Dupixent (dupilumab) is a brand-name injection that’s ... in symptoms as soon as 2 weeks after starting treatment. But it can take several weeks or months before Dupixent’s full effects ...

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injections as an add-on therapy for adults with chronic obstructive pulmonary disease (COPD) who continue to struggle ...

Analysts predict peak annual sales of around $2.5 billion for Dupixent, which the FDA approved in March last year for eczema – known medically as moderate-to-severe atopic dermatitis – after ...

Given those numbers, Sanofi and Regeneron have high hopes for Dupixent in CSU, particularly after Novartis' follow ... urticaria and food allergies – before planning its next steps.